A career in cancer research turns out to be the perfect prep for a grueling personal adventure
Biotech Voices is a collection of exclusive opinion editorials from some of the leading voices in biopharma on the biggest industry questions today. Think you have a voice that should be heard? Reach out to Amber Tong.
Editor’s note: Not long after Kristen Hege sat down with a panel of R&D experts I’d marshaled at JP Morgan to discuss the challenges and opportunities in early-stage cancer R&D, she reached out to me about her decision to put her career on hold to hike the entire Pacific Crest Trail — all 2,658 miles of it. On Saturday, she began the long march, planning to make her way along a trail that was currently either burning with desert heat or packed with snow. She wanted to explain to the industry why she was doing this and how it relates to R&D. And I eagerly accepted the first of several columns — which you can see below — we plan to publish in the months ahead.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 170,200+ biopharma pros reading Endpoints daily — and it's free.